Results 341 to 350 of about 2,984,719 (362)
Some of the next articles are maybe not open access.

On the reversibility of tumor cells

Medical Hypotheses, 1981
A review is given of several cases in which a neoplastic cell becomes a normal one. Emphasis is placed on the Lucké adenocarcinoma in the frog and on the case of terminal differentiation. The mysteries of cell fusion studies are discussed as well as the experiments of Mintz et al on teratocarcinoma of the mouse. In the case of the Lucké adenocarcinoma,
openaire   +3 more sources

Heterogeneity of Tumor Cells

2015
Investigations of cell clones isolated in vitro, or selected in vivo, have shown that tumor cell populations are heterogenous. The isolated cell clones or cell subpopulations originating from a single tumor may differ in a variety of biological and biochemical characteristics.
V. Ujházy, J. Siracký
openaire   +3 more sources

Circulating Tumor Cells

2010
Circulating tumor cells (CTCs) can be separated and characterized from normal hematopoietic cellular constituents by a variety of methods. Different strategies have included separation by physical characteristics, such as size or weight, or by biological characteristics, such as expression of epithelial or cancer-specific markers.
Daniel F. Hayes, Jeffrey B. Smerage
openaire   +3 more sources

Cell migration in tumors

Current Opinion in Cell Biology, 2005
Invasion of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. This requires chemotactic migration of cancer cells, steered by protrusive activity of the cell membrane and its attachment to the extracellular matrix.
Jeffrey Wyckoff   +2 more
openaire   +3 more sources

Germ Cell Tumors

Hematology/Oncology Clinics of North America, 1992
The development of modern surgical staging and effective chemotherapy regimens has markedly improved outcome of treatment of ovarian germ cell tumors. Almost all patients with completely resected tumors will survive their disease. Those with tumors other than dysgerminoma should all receive adjuvant chemotherapy. Patients with stage IA dysgerminoma can
openaire   +3 more sources

Leydig Cell Tumor [PDF]

open access: possible, 2019
Alessia Bertolotti, Maurizio Colecchia
openaire   +1 more source

Tumor Cell Resistance

2015
Rosenblum M. L.   +3 more
openaire   +4 more sources

T cells and tumors

Immunology Today, 1992
Hub F.J. Dullens   +2 more
openaire   +2 more sources

B-Cell Tumors

2008
Christian Ottensmeier, Freda Stevenson
openaire   +1 more source

Home - About - Disclaimer - Privacy